Forward-looking StatementsThis news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's newly developed High-Efficiency Oxygen Inhaler. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. Contact Us Dehaier Medical Systems Limited Surie Liu+86 10-5166-0080 firstname.lastname@example.org Dehaier Medical Systems Limited Tina He+86 10-5166-0080 email@example.com The Equity Group Inc. Katherine Yao+86 10-6587-6435 firstname.lastname@example.org In America The Equity Group Inc. Adam Prior(212) 836-9606 email@example.com SOURCE Dehaier Medical Systems Ltd.